Advertisement.
Advertisement.
Advertisement
Advertisement.
SPRB Spruce Biosciences Inc
2,993
| Market Cap | $22.42M |
| Volume | 117,492.00 |
| 52-Wk High | $5.95 |
| 52-Wk Low | $0.503 |
Spruce Biosciences Recognized as a Bay Area Best Place to Work
Business Wire•2 months ago
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant...
Share to Feed
Spruce Biosciences collaborates with HMNC Brain Health to advance tildacerfont, a precision therapeutic for major depressive disorder, using the Cortibon Genetic Selection Tool.
read more...
Benzinga•2 months ago
Spruce Biosciences, Inc. (Nasdaq: SPRB) (Spruce), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with...
Business Wire•2 months ago
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine disorders with significant unmet medical need...
Business Wire•2 months ago
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical...
Business Wire•2 months ago
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical...
Business Wire•2 months ago
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical...
Business Wire•2 months ago
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical...
Business Wire•3 months ago
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical...
Business Wire•3 months ago
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical...
Business Wire•3 months ago